Abstract
Molecular simulations play important roles in understanding the lifecycle of the SARS-CoV-2 virus and contribute to the design and development of antiviral agents and diagnostic tests for COVID. Here, we discuss the insights that such simulations have provided and the challenges involved, focusing on the SARS-CoV-2 main protease (Mpro) and the spike glycoprotein. Mpro is the leading target for antivirals, while the spike glycoprotein is the target for vaccine design. Finally, we reflect on lessons from this pandemic for the simulation community. Data sharing initiatives and collaborations across the international research community contributed to advancing knowledge and should be built on to help in future pandemics and other global challenges such as antimicrobial resistance.
Original language | English |
---|---|
Pages (from-to) | 3249-3263 |
Number of pages | 15 |
Journal | The Journal of Physical Chemistry Letters |
Volume | 16 |
Issue number | 13 |
Early online date | 21 Mar 2025 |
DOIs | |
Publication status | Published - 3 Apr 2025 |
Bibliographical note
Publisher Copyright:© 2025 The Authors.
Keywords
- SARS-CoV-2
- Mpro
- Spike
- QM/MM
- Molecular Simulations
- Exascale Simulations
Fingerprint
Dive into the research topics of 'A Reflection on the Use of Molecular Simulation to Respond to SARS-CoV-2 Pandemic Threats'. Together they form a unique fingerprint.Equipment
-
HPC (High Performance Computing) and HTC (High Throughput Computing) Facilities
Alam, S. R. (Manager), Williams, D. A. G. (Manager), Eccleston, P. E. (Manager) & Greene, D. (Manager)
Facility/equipment: Facility